Jury royalty affirmed but injunction partially vacated because Defendant depends entirely on sales of enjoined products

Bio-Rad Labs. v. 10X Genomics was decided on August 3, 2020, on appeal from the District of Delaware. The jury found that Plaintiff Bio-Rad’s three asserted patents were valid and willfully infringed, and “awarded damages in the amount of $23,930,716.” Post-trial, the district court denied Defendant 10X’s motion for  JMOL, …

No irreparable harm where plaintiff licenses the patent and defendant competes with the licensees

Verinata Health v. Ariosa Diagnostics is a nonprecendential case decided on April 24, 2020, on appeal from the Northern District of California. The asserted patents concern DNA sequence testing. After trial, the jury found two patents owned by Plaintiffs Verinata and Illumina valid and infringed, and awarded “approximately $27 million …

Injunction, enhanced damages, and attorney fees vacated after finding one patent invalid under Section 101

Chamberlain Group v. Techtronic Industries was decided on August 21, 2019 on appeal from the Northern District of Illinois. After the jury found plaintiff Chamberlain’s patents infringed and not invalid, the district court the district court granted an injunction, enhanced damages and attorney fees. The district court denied defendant Techtronic’s motion for JMOL …

Federal Circuit on determining an ongoing royalty for patent infringement

Section 283 of the Patent Act provides that courts “may grant injunctions in accordance with the principles of equity to prevent the violation of any right secured by patent, on such terms as the court deems reasonable.” There are several types of relief for ongoing infringement that a court can …

Denial of permanent injunction vacated because willingness to license does not necessarily mean no irreparable harm – modified opinion –

Texas Advanced Optoelectronic v. Renesas was decided on July 9, 2018 on appeal from the Eastern District of Texas. The Federal Circuit granted petition for rehearing and reissued the opinion, modifying the opinion released on May 1, 2018. The principal change relates to the evidence relied on by Texas Advanced in its …

Infringement, direct competition, and past harms support permanent injunction against generics company

Endo v. Teva is a nonprecedential case decided on May 16, 2018 on appeal from the Southern District of New York. The district court found all asserted claims by plaintiff Endo against defendant Teva not invalid, and found all but two asserted claims infringed. The district court then issued a permanent injunction against …

Federal Circuit on showing a causal nexus for an injunction of a multi-component product

A party seeking an injunction must make a clear showing that it is at risk of irreparable harm. In cases where “the accused product includes many features of which only one (or a small minority) infringe,” a finding that the patentee will be at risk of irreparable harm “does not …

Denial of permanent injunction vacated because willingness to license does not necessarily mean no irreparable harm

This opinion was superseded.   Texas Advanced Optoelectronic v. Renesas was decided on May 1, 2018 on appeal from the Eastern District of Texas. Plaintiff Texas Advanced sued defendant Renesas for patent infringement, trade secret misappropriation, breach of contract, and tortious interference. Before trial, the district court granted Renesas’s summary judgment motion …

Lost profits award reversed because of non-infringing substitute; permanent injunction then vacated

Presidio v. American Technical Ceramics was decided on November 21, 2017 on appeal from the Southern District of California. The invention concerned capacitors for storing and releasing energy. The district court granted defendant ATC’s motion for summary judgment on absolute intervening rights. The jury then returned a verdict of direct and induced infringement, …

For multi-component products, causal nexus only requires some connection between the feature and product demand

Genband v. Metaswitch was decided on July 10, 2017 on appeal from the Eastern District of Texas. There, after a jury found that Defendant Metaswitch infringed claims of Plaintiff Genband’s patents, and that the claims were not invalid, Genband moved for a permanent injunction. The district court denied the request because “Genband …